: Comparison of the effect of Rosemary essential oil and Comfrey ointment on the severity of pain and bruising caused by enoxaparin injection in cardiac patients
Phase 3
Recruiting
- Conditions
- Acute coronary syndrome.Acute ischemic heart disease, unspecifiedI24.9
- Registration Number
- IRCT20240430061604N1
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Full consciousness
Minimum literacy for counting numbers
Not receiving medication at the same time with subcutaneous injection
Exclusion Criteria
Death of the patient
discharge before 48 hours
receipt of intravenous anticoagulant for any reason
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of pain and bruising. Timepoint: Pain intensity immediately after injection and 5 minutes after injection. Method of measurement: Using visual pain scale.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Rosemary essential oil and Comfrey ointment in reducing enoxaparin-induced pain and bruising in cardiac patients (IRCT20240430061604N1)?
How does the efficacy of Rosemary essential oil and Comfrey ointment compare to standard-of-care treatments for enoxaparin injection site pain and bruising in I24.9 patients?
Which biomarkers correlate with response to Rosemary essential oil or Comfrey ointment in mitigating enoxaparin-related injection site complications in acute coronary syndrome?
What are the potential adverse events and safety profiles of Rosemary essential oil and Comfrey ointment when used alongside enoxaparin in cardiac patients?
Are there other herbal compounds or combination therapies with similar analgesic and anti-inflammatory effects as Rosemary and Comfrey for anticoagulant-related injection site reactions?